On May 8, 2024, AbbVie Inc announced that it held its annual general meeting of shareholders on May 3, 2024 and declared voting results. The Company stated that the shareholders' proposal submitted by John Chevedden, on behalf of Kenneth Steiner, regarding a simple majority vote was not presented at the 2024 Annual Shareholder Meeting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166 USD | -2.59% |
|
-2.81% | +7.09% |
01/07 | Merus Names New Chief Medical Officer | MT |
01/07 | AbbVie: new CEO takes up post | CF |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.09% | 293B | |
+55.55% | 816B | |
+39.97% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+13.70% | 238B | |
+1.19% | 222B | |
+13.23% | 218B | |
+7.87% | 167B | |
-3.33% | 158B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Declaration of Voting Results of the AbbVie Inc